What Statistics Collaborative does

Statistics Collaborative is a US-based biostatistics consulting firm founded in 1990 and headquartered in Cary, North Carolina (with a Princeton mailing footprint), now operating as a wholly integrated subsidiary of WCG Clinical. The firm specializes in statistical consulting services for regulated clinical trials, including protocol and trial design, statistical analysis plan development, statistical oversight and guidance, and managed Data Monitoring Committee services that deliberate over unblinded data to make continuation and patient-safety recommendations. It serves pharmaceutical sponsors, contract research organizations, and research sites across at least eight therapeutic areas — hematology/oncology, CNS, cardiovascular, metabolic, infectious disease, dermatology, immunology, and gastroenterology — with documented experience supporting regulatory approvals including a Breakthrough Therapy-designated program.

The company's commercial offering is a professional services engagement model delivered on a project or retainer basis, with no publicly disclosed pricing. As part of WCG Clinical's integrated solutions platform, Statistics Collaborative's services are distributed through WCG's direct enterprise sales force, complemented by content marketing (case studies, whitepapers, thought-leadership articles authored by figures such as Dr. Janet Wittes), a consultation booking system, and sponsored industry events such as MAGI@home 2026. Its offerings are now surfaced within WCG's "Data & Insights" and "Study Planning & Review" solution categories for both Sponsors & CROs and Research Sites buyer segments.

On the technology side, Statistics Collaborative does not operate a standalone proprietary software product; rather, its services are enabled by WCG Clinical's broader ClinSphere platform ecosystem, which includes modules such as AIMS, IRBNet, eReview Manager, InvestigatorSpace, Total Enrollment, Total Feasibility, eResearch Enterprise CTMS, Clinical Trial Listing Service (CTLS), and ClinSphere Trial IntelX. The company's standalone web presence (statcollab.com) was consolidated into wcgclinical.com in 2023, and it now operates under the trade name "WCG Statistics Collaborative" with no disclosed separate headcount, revenue, or funding history.

Name

Statistics Collaborative

Legal name

Statistics Collaborative

Website

https://statcollab.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

11–50 employees

Short description

Statistics Collaborative provides biostatistics consulting, trial design, and Data Monitoring Committee services for pharmaceutical sponsors, CROs, and research sites, operating as a wholly integrated subsidiary of WCG Clinical since its 2023 brand consolidation.

Ownership category

akta.pro rank

Product category

Biostatistics Consulting

NAICS

Other Scientific and Technical Consulting Services (54169), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)

akta.pro primary industry

Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO)

akta.pro secondary industries

Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Biostatistics consulting
• Clinical trial statistics
• Statistical analysis plans
• Data monitoring committees
• Protocol design services

Headquarters

HQ city

Princeton

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Statistical Consulting Services: Professional consulting services for clinical trial design, statistical analysis plan development, and statistical oversight. Services are likely billed on a project or retainer basis as part of WCG Clinical's integrated clinical research solutions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Statistics Collaborative provides biostatistics consulting services for clinical trials, including protocol and trial design, statistical analysis plan development, statistical oversight, and managed Data Monitoring Committee services. The firm enriches sponsors' clinical development plans by offering additional statistical capabilities and independent oversight, now operating as part of WCG Clinical's integrated clinical research solutions platform. Services are delivered by clinical, medical, and statistical experts across multiple therapeutic areas including oncology, CNS, cardiovascular, metabolic, infectious disease, dermatology, immunology, and gastroenterology.

Product overview

Statistics Collaborative, now consolidated into WCG Clinical, offers a platform-plus-modules architecture of clinical trial statistical services and related technology products. The core services include Statistical Consulting (protocol and trial design, statistical analysis plan development, statistical oversight), Trial Design & Protocol Planning, and Data Monitoring Committee management. These services are supported by an integrated technology ecosystem including ClinSphere® platform and its associated modules (AIMS®, eReview Manager, InvestigatorSpace®, IRBNet, Total Enrollment, Total Feasibility, eResearch Enterprise CTMS, Clinical Trial Listing Service, and ClinSphere Trial IntelX™), which collectively enable study planning, IRB review, site management, participant recruitment, and data monitoring across clinical trials.

Differentiator

Problem solved

Functional benefit

Products and services

• Statistical Consulting Enriches clinical development plans for pharmaceutical and biotechnology sponsors requiring additional statistical capabilities. The service includes protocol and trial design, statistical analysis plan development, and statistical oversight and guidance across multiple therapeutic areas.
• Trial Design & Protocol Planning Provides expert clinical, medical, and statistical input to improve study design quality, ensure appropriate patient population and endpoint selection, reduce the frequency of protocol amendments, inform study decisions, and increase overall validity and quality of clinical studies.
• Data Monitoring Committee Services Provides managed Data Monitoring Committees that deliberate over un-blinded clinical trial data to deliver recommendations on trial continuation and progression. The streamlined approach ensures patient safety oversight and effective decision-making throughout the clinical trial lifecycle.

Quantifiable outcome

• Successfully supported Breakthrough Therapy in obtaining regulatory approval

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• IQVIA: IQVIA is the world's largest clinical research services provider, with an extensive biostatistics, bioinformatics, and clinical data analytics portfolio that overlaps with Statistics Collaborative's offerings at scale.
• Parexel International: Parexel is a global full-service CRO with a large biostatistics and statistical programming practice, including FSP offerings that directly compete with Statistics Collaborative's niche services.
• Labcorp Drug Development (formerly Covance): Labcorp/Drug Development is a large CRO with integrated biostatistics and central lab services, offering a bundled statistical-services delivery model similar to Statistics Collaborative's integration into WCG.
• ICON plc: ICON is a global CRO with a substantial biostatistics and FSP practice, competing directly with Statistics Collaborative for outsourced statistical work from pharmaceutical sponsors.

Emerging players

• Evidera (PPD/Pharmaceutical Product Development): Evidera is a health economics and outcomes research consultancy within PPD that intersects with clinical trial biostatistics, providing overlapping but more specialized analytics services relative to Statistics Collaborative.

Direct peers

• Premier Research: Premier Research is a CRO offering specialized biostatistics, regulatory, and clinical development services, often partnering with biotech and rare disease sponsors in a manner comparable to Statistics Collaborative.
• Medpace: Medpace is a mid-sized CRO with strong biostatistics and data sciences capabilities, competing for clinical trial statistical consulting and analysis work from pharma and biotech sponsors.
• Cytel: Cytel is a leading biostatistics and statistical programming CRO, offering trial design, SAP development, and FSP biostatistics services closely overlapping with Statistics Collaborative's core offerings to pharmaceutical sponsors.
• MMS Holdings: MMS Holdings is a clinical research services firm specializing in biostatistics, statistical programming, and clinical data management, serving pharma and biotech sponsors with very similar services to Statistics Collaborative.
• Rho (acquired by Clinipace): Rho is a contract research organization known for biostatistics, data management, and regulatory affairs, providing overlapping clinical trial biostatistics services to sponsors and CROs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Statistics Collaborative